Risk-Reducing Salpingectomy in Canada: A Survey of Obstetrician-Gynaecologists

Journal of Obstetrics and Gynaecology Canada

Volumn 35, Issue 7, 2013, Pages 627-634

  Reade, Clare J ^a   Finlayson, Sarah ^b   McAlpine, Jessica ^b   Tone, Alicia A ^a   Fung Kee Fung, Michael ^c   Ferguson, Sarah E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

High grade serous cancer; Ovarian cancer; Prevention; Salpingectomy

Indexed keywords

ARTICLE; CANADIAN; CANCER PREVENTION; FALLOPIAN TUBE; FERTILITY PRESERVATION; GYNECOLOGIST; HUMAN; OBSTETRICIAN; OVARY CANCER; PHYSICIAN ATTITUDE; PROFESSIONAL KNOWLEDGE; PROPHYLACTIC SURGICAL PROCEDURE; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; RISK REDUCING SALPINGECTOMY; RISK REDUCTION; SALPINGECTOMY; UTERINE TUBE LIGATION; CANADA; CLINICAL PRACTICE; CYSTADENOCARCINOMA; FEMALE; GYNECOLOGIC SURGERY; GYNECOLOGY; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HIGH GRADE SEROUS CANCER; HYSTERECTOMY; METHODOLOGY; PREVENTION; PROFESSIONAL PRACTICE; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; STATISTICS;

HIGH GRADE SEROUS CANCER; OVARIAN CANCER; PREVENTION; SALPINGECTOMY;

ATTITUDE OF HEALTH PERSONNEL; CANADA; CYSTADENOCARCINOMA, SEROUS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; GYNECOLOGY; HEALTH CARE SURVEYS; HUMANS; HYSTERECTOMY; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL PRACTICE; QUALITATIVE RESEARCH; RISK ASSESSMENT; SALPINGECTOMY;

EID: 84882456149     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30894-X     Document Type: Article

References (32)

1. Canadian Cancer Society's Steering Committee on Cancer Statistics Canadian Cancer Statistics 2012 2012, Canadian Cancer Society, Toronto, ON, http://www.cancer.ca/en/cancer-information/cancer-101/canad1an-cancer-stat1st1cs-publ1cation/?region=on. Accessed May 14.
2. Buys S.S., Partridge E., Black A., Johnson C.C., Lamerato L., Isaacs C., et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 2011, 305(22):2295-2303.
3. Chan A., Gilks B., Kwon J., Tinker A.V. New insights into the pathogenesis of ovarian carcinoma: time to rethink ovarian cancer screening. Obstet Gynecol 2012, 120(4):935-940.
4. Salvador S., Gilks B., Kobel M., Huntsman D., Rosen B., Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer 2009, 19(1):58-64.
5. Lurie G., Wilkens L.R., Thompson P.J., Matsuno R.K., Carney M.E., Goodman M.T. Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis. Gynecol Oncol 2010, 119(2):278-284.
6. Tone A.A., Salvador S., Finlayson S.J., Tinker A.V., Kwon J.S., Lee C.H., et al. The role of the fallopian tube in ovarian cancer. Clin Adv Hematol Oncol 2012, 10(5):296-306.
7. Kurman R.J., Shih I.-M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol 2011, 42(7):918-931.
8. The Society of Gynecologic Oncology of Canada GOC statement regarding salpingectomy and ovarian cancer prevention 2011, 1-3. http://www.g-o-c.org/uploads/11sept15_gocevidentiarystatement_final_en.pdf. Accessed Dec. 15, 2012.
9. Thiel J. It sounded like a good idea at the time. J Obstet Gynaecol Can 2012, 34(7):611-612.
10. Tone A., McAlpine J., Finlayson S., Gilks C.B., Heywood M., Huntsman D., et al. It sounded like a good idea at the time. J Obstet Gynaecol Can 2012, 34(12):1127-1130.
11. Fayerman P. Removing Fallopian tubes during hysterectomies cuts ovarian cancer: BC study; 2010 2013, http://www2.canada.com/ topics/bodyandhealth/story.html?id=3495775. Accessed May 12.
12. CBC Fallopian tube removal cuts ovarian cancer risk. CBC News: Health 2010 Accessed May 12. http://www.cbc.ca/news/health/%20story/2010/09/08/fallopian-ovarian-cancer.html.
13. Nelson R. Routine removal of fallopian tubes urged to reduce risk for ovarian cancer. Medscape Medical News 2010, http://www.medscape.com/viewarticle/728729 Accessed May 12, 2013.
14. Sezik M., Ozkaya O., Demir F., Sezik H.T., Kaya H. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 2007, 33(6):863-869.
15. Lefebvre G., Allaire C., Jeffrey J. Vilos G; SOGC Clinical Gynaecology Committee. Hysterectomy. SOGC Clinical Practice Guidelines No. 109, January 2002. J Obstet Gynaecol Can 2002, 24(1):37-61. quiz 74-36.
16. Hirth R., Zbella E., Sanchez M., Prieto J. Microtubal reanastomosis: success rates as compared to in vitro fertilization. J Reprod Med 2010, 55(3-4):161-165.
17. Statistics Canada Population and dwelling counts, for Canada, provinces and territories, 2011 and 2006 censuses. 2011 2013, http://www12.statcan.gc.ca/census-recensement/2011/dp-pd/hlt-fst/pd-pl/Table-Tableau.cfm?LANG=Eng&T= 101&SR=1&S=3&O=D. Accessed Mar 24.
18. Shuster L.T., Gostout B.S., Grossardt B.R., Rocca W.A. Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int 2008, 14(3):111-116.
19. Rocca W.A., Grossardt B.R., de Andrade M., Malkasian G.D., Melton L.J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006, 7(10):821-828.
20. Rivera C.M., Grossardt B.R., Rhodes D.J., Brown R.D., Roger V.L., Melton L.J., et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009, 16(1):15-23.
21. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007, 69(11):1074-1083.
22. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008, 70(3):200-209.
23. Rocca W.A., Grossardt B.R., Geda Y.E., Gostout B.S., Bower J.H., Maraganore D.M., et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 2008, 15(6):1050-1059.
24. Verhulst G., Vandersteen N., van Steirteghem A.C., Devroey P. Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme. Hum Reprod 1994, 9(4):624-628.
25. Dar P., Sachs G.S., Strassburger D., Bukovsky I., Arieli S. Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod 2000, 15(1):142-144.
26. Strandell A., Lindhard A., Waldenstrom U., Thorburn J. Prophylactic salpingectomy does not impair the ovarian response in IVF treatment. Hum Reprod 2001, 16(6):1135-1139.
27. Finch A., Beiner M., Lubinski J., Lynch H.T., Moller P., Rosen B., et al. Hereditary Ovarian Cancer Clinical Study Group. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006, 296(2):185-192.
28. Kauff N.D., Satagopan J.M., Robson M.E., Scheuer L., Hensley M., Hudis C.A., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002, 346(21):1609-1615.
29. Kwon J.S., Tinker A., Pansegrau G., McAlpine J., Housty M., McCullum M., et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 2012, 121(1):14-24.
30. Centre Oscar Lambret Radical fimbriectomy for young BRCA mutation carriers at risk of pelvic serous carcinoma. NCT01608074 2012, Available at: http://clinicaltrials.gov/ct2/show/NCT01608074?term= salpingectomy&rank=6. Accessed Dec 17, 2012.
31. Lee Y., Miron A., Drapkin R., Nucci M.R., Medeiros F., Saleemuddin A., et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007, 211(1):26-35.
32. Thiel J.A., Carson G.D. Cost-effectiveness analysis comparing the essure tubal sterilization procedure and laparoscopic tubal sterilization. J Obstet Gynaecol Can 2008, 30(7):581-585.